The system, called EDS-FLU, was tested in two randomized international clinical trials involving more than 500 adults with chronic rhinosinusitis with or without nasal polyps. Patients used EDS-FLU or placebo twice daily for 24 weeks.
Study results published in the Journal of Allergy and Clinical Immunology: App showed that EDS-FLU significantly improved sinusitis symptom scores and CT scan results compared to placebo. Patients using EDS-FLU also reported fewer flares and sinus infections.
EDS-FLU works by using the patient’s own breath to deliver medication deep into the sinuses. This method of application is more effective than traditional nasal sprays, which usually only reach the front of the nose.
News materials cannot be equated with a doctor’s prescription. Consult an expert before making a decision.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
